Organizing oncology and haematology evidence into source-linked answers
Medical evidence keeps expanding while clinicians have limited time for research. Answering a medical question requires gathering and interpreting guidelines, regulatory information and publications, then checking their original sources and clinical context.
AVOR Medical Intelligence offers a research prototype that organizes oncology and haematology evidence into source-linked answers. It helps professionals research guidelines, EMA information and scientific studies.
What stands out about AVOR Medical Intelligence
Co-founders Enver Aydilek and Florian Weißinger are haematology/oncology physicians; Max Schüler is a dentist.
Life Science Factory confirms support for AVOR through its Entrepreneurial Life Science Accelerator programme, ELSA.
Won the Audience Award at the ELSA Pitch Bowl 2026 for its source-based oncology and haematology knowledge platform.
Co-founder Max Schüler previously co-founded Quickdoctor (2018–2024) and DeepDetectAI (2024–2026).
Won the Life Science special prize at Göttingen University’s LIFT-OFF startup competition in May 2026.
Won the Health special prize at the HSBI Startup Award in September 2026 for its oncology and haematology evidence platform.
Co-founder Friedrich Schwarz led a 2026 npj Digital Medicine study using machine learning to assess myeloma stem-cell treatment risks.
Co-founder Max Schüler completed clinical and research stays at Harvard University and Massachusetts General Hospital.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.